Your session is about to expire
← Back to Search
Orthopedic Implant
Enrolled Subjects for Total Knee Replacement
N/A
Waitlist Available
Research Sponsored by Exactech
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up annually through study completion, maximum of 10-years
Awards & highlights
No Placebo-Only Group
Summary
A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ annually through study completion, maximum of 10-years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~annually through study completion, maximum of 10-years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hospital for Special Surgery Knee Score
Knee Society Score
Oxford Knee Score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Enrolled SubjectsExperimental Treatment1 Intervention
Patients recruited from the population undergoing knee arthroplasty as part of standard of care. Patients who meet all the inclusion criteria and none of the exclusion criteria should be presented with an opportunity to undergo the informed consent process.
Find a Location
Who is running the clinical trial?
ExactechLead Sponsor
15 Previous Clinical Trials
25,788 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger